Ownership stake disclosure by TPG GP A, LLC (amended)
TPG GP A, LLC, filed by
ALLO
Allogene Therapeutics, Inc. SEC filings
Every EDGAR filing for Allogene Therapeutics, Inc. (ALLO), newest first, with AI summaries and stories.
- Ticker
- ALLO
- CIK
- 1737287
- Latest filing
- Sep 30
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
SCHEDULE 13D/AAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE 4Allogene Therapeutics, Inc.ALLOLIVE Earl Martin Douglas, insider filing for ALLO
Earl Martin Douglas, reporting
144Allogene Therapeutics, Inc.ALLOLIVE Earl Martin Douglas, planned sale of ALLO shares
Earl Martin Douglas, reporting
EFFECTAllogene Therapeutics, Inc.ALLOLIVE SCHEDULE 13G/AAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P. (amended)
Frazier Life Sciences Public Fund, L.P., filed by
S-3Allogene Therapeutics, Inc.ALLOLIVE 10-QAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE SCHEDULE 13G/AAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by Arie Belldegrun (amended)
Arie Belldegrun, filed by
SCHEDULE 13GAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
4Allogene Therapeutics, Inc.ALLOLIVE Zachary Roberts, insider filing for ALLO
Zachary Roberts, reporting
4Allogene Therapeutics, Inc.ALLOLIVE 7 insider filings
Joshua A Kazam, insider filing for ALLO
Show all 7
- 4Insider filing for ALLO
- 4Insider filing for ALLO
- 4Insider filing for ALLO
- 4Insider filing for ALLO
- 4Insider filing for ALLO
- 4Insider filing for ALLO
- 4Insider filing for ALLO
Joshua A Kazam, reporting
8-KAllogene Therapeutics, Inc.ALLOLIVE 424B5Allogene Therapeutics, Inc.ALLOLIVE DEFA14AAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE SCHEDULE 13G/AAllogene Therapeutics, Inc.ALLOLIVE 2 13G filings
Ownership stake disclosure by CITADEL ADVISORS LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
CITADEL ADVISORS LLC, filed by
SCHEDULE 13G/AAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by Arie Belldegrun (amended)
Arie Belldegrun, filed by
SCHEDULE 13G/AAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by David D Chang (amended)
David D Chang, filed by
10-QAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE ARSAllogene Therapeutics, Inc.ALLOLIVE DEFA14AAllogene Therapeutics, Inc.ALLOLIVE DEF 14AAllogene Therapeutics, Inc.ALLOLIVE SCHEDULE 13GAllogene Therapeutics, Inc.ALLOLIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P.
Frazier Life Sciences Public Fund, L.P., filed by
4Allogene Therapeutics, Inc.ALLOLIVE Annie Yoshiyama, insider filing for ALLO
Annie Yoshiyama, reporting
144Allogene Therapeutics, Inc.ALLOLIVE Annie Yoshiyama, planned sale of ALLO shares
Annie Yoshiyama, reporting
PRE 14AAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE 424B5Allogene Therapeutics, Inc.ALLOLIVE 424B5Allogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE 4Allogene Therapeutics, Inc.ALLOLIVE Benjamin Machinas Beneski, insider filing for ALLO
Benjamin Machinas Beneski, reporting
144Allogene Therapeutics, Inc.ALLOLIVE Benjamin Machinas Beneski, planned sale of ALLO shares
Benjamin Machinas Beneski, reporting
4Allogene Therapeutics, Inc.ALLOLIVE 2 insider filings
Benjamin Machinas Beneski, insider filing for ALLO
Show all 2
- 4Insider filing for ALLO
- 4Insider filing for ALLO
Benjamin Machinas Beneski, reporting
144Allogene Therapeutics, Inc.ALLOLIVE 2 Form 144 notices
Benjamin Machinas Beneski, planned sale of ALLO shares
Show all 2
- 144Planned insider sale of ALLO shares
- 144Planned insider sale of ALLO shares
Benjamin Machinas Beneski, reporting
S-8Allogene Therapeutics, Inc.ALLOLIVE 10-KAllogene Therapeutics, Inc.ALLOLIVE 8-KAllogene Therapeutics, Inc.ALLOLIVE